Standard BioTools Inc.LABNASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
+56.7%/yr
Long-term compound
Percentile
P87
Within normal range
vs 5Y Ago
9.5x
Strong expansion
Streak
4 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.21% |
| Q3 2025 | -3.11% |
| Q2 2025 | -3.90% |
| Q1 2025 | -5.35% |
| Q4 2024 | -10.15% |
| Q3 2024 | -3.84% |
| Q2 2024 | -8.86% |
| Q1 2024 | 140.71% |
| Q4 2023 | -4.78% |
| Q3 2023 | -4.65% |
| Q2 2023 | -4.26% |
| Q1 2023 | -4.78% |
| Q4 2022 | -5.93% |
| Q3 2022 | -5.94% |
| Q2 2022 | 62.21% |
| Q1 2022 | -1.19% |
| Q4 2021 | -2.47% |
| Q3 2021 | -2.46% |
| Q2 2021 | -5.20% |
| Q1 2021 | -6.02% |
| Q4 2020 | 0.55% |
| Q3 2020 | 14.39% |
| Q2 2020 | -2.71% |
| Q1 2020 | 9.59% |
| Q4 2019 | -1.70% |
| Q3 2019 | -5.07% |
| Q2 2019 | -2.63% |
| Q1 2019 | -4.02% |
| Q4 2018 | 20.36% |
| Q3 2018 | -2.63% |
| Q2 2018 | -3.93% |
| Q1 2018 | -6.14% |
| Q4 2017 | -1.59% |
| Q3 2017 | 4.77% |
| Q2 2017 | -4.70% |
| Q1 2017 | -4.55% |
| Q4 2016 | -4.38% |
| Q3 2016 | -6.32% |
| Q2 2016 | -3.50% |
| Q1 2016 | -4.48% |